2006
|
||
|---|---|---|
|
January
January; 21 (1): 1 - 249 |
February
February; 21 (2): 251 - 558 |
March
March; 21 (3): 559 - 833 |
|
April
April; 21 (4): 835 - 1143 |
May
May; 21 (5): 1145 - 1460 |
June
June; 21 (6): 1461 - 1747
Supplement: Contrast-induced nephropathy: prevalence, consequences and strategies for risk reduction in clinical practice |
|
July
July; 21 (7): 1749 - 2046
Supplement: Managing Cardiovascular Risk in Renal Transplant Recipients: The Role of Everolimus
Supplement: Dialysis Initiatives May 18-20 2005, Madrid, Spain
Supplement: XLIII ERA-EDTA CONGRESS, July 15-18, 2006 - Glasgow, United Kingdom |
August
August; 21 (8): 2047 - 2345 |
September
September; 21 (9): 2347 - 2680 |
|
October
Supplement: Uptake of biosimilar therapies - opportunities and obstacles October; 21 (10): 2681 - 3004 |
November
November; 21 (11): 3005 - 3348 |
December
December; 21 (12): 3349 - 3616 |